EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW)

CUSIP: 28202V116

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / *W EXP 12/31/202
Total 13F shares
2,074,996
Share change
-9,074
Total reported value
$359,293
Price per share
$0.17
Number of holders
9
Value change
-$1,063
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 28202V116?
CUSIP 28202V116 identifies EFTRW - EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) as of Q2 2023

As of 30 Jun 2023, EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,074,996 shares. The largest 9 holders included ARISTEIA CAPITAL LLC, WHITEBOX ADVISORS LLC, MMCAP International Inc. SPC, III Capital Management, TENOR CAPITAL MANAGEMENT Co., L.P., Sea Otter Advisors LLC, UBS Group AG, WOLVERINE ASSET MANAGEMENT LLC, and Tower Research Capital LLC (TRC). This page lists 9 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.